Skip to main content
. 2022 Apr 20;62(SI):SI74–SI81. doi: 10.1093/rheumatology/keac243

Table 2.

Primary and secondary efficacy outcomes

Outcomes β 95% CI
Primary
 RCS −0.067 −0.19, 0.059
Secondary
 Raynaud attacks frequency 0.48 −0.25, 1.21
 Raynaud attacks duration −39.80 −115.65, 36.05
 NRS hand warmth 0.086 −0.041, 0.21
 Impact Raynaud −0.088 −0.21, 0.035
 HAQ_DI −0.036 −0.046, −0.026

NRS: numeric rating scale.

The reference category was normal gloves.

Linear mixed models were performed with the primary and secondary outcomes as dependent variables, the type of gloves as the independent variable, adjusted for prior RCS.

A β of −0.067 means that wearing 8% silver fibre gloves gave a 0.067 lower RCS compared with normal gloves, which was a nonsignificant difference.